tiprankstipranks
Viridian Therapeutics (GB:0K1R)
LSE:0K1R
Holding GB:0K1R?
Track your performance easily

Viridian Therapeutics (0K1R) Ownership - Who Owns Viridian Therapeutics?

1 Followers

Viridian Therapeutics (0K1R) Ownership Overview

4.38%21.58%60.26%10.74%3.03%
60.26% Other Institutional Investors
10.74% ETFs
3.03% Public Companies and
Individual Investors
The ownership structure of Viridian Therapeutics (GB:0K1R) stock is a mix of institutional, retail, and individual investors. Approximately 92.59% of the company’s stock is owned by Institutional Investors, 4.38% is owned by Insiders, and 3.03% is owned by Public Companies and Individual Investors.
The ownership structure of Viridian Therapeutics (GB:0K1R) stock is a mix of institutional, retail, and individual investors. Approximately 81.84% of the company’s stock is owned by Institutional Investors, 4.38% is owned by Insiders, and 10.74% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Sep 30, 2024
Stephen F. Mahoney
President & Ceo,director
xxxxxxxxxxxxx
$499262
Sep 17, 2024
Fairmount Funds Management Llc
Director, >10% Owner
xxxxxxxxxxxxx
$30000000
Jan 24, 2024
Fairmount Funds Management Llc
Director, >10% Owner
xxxxxxxxxxxxx
$9999990

Recent Hedge Fund Trading Activity

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
3,702,837Institution4.67%66,884,345
3,445,813Insider4.35%62,241,720
3,445,813Institution4.35%62,241,720
3,190,415Institution4.03%57,628,466
2,812,665Institution3.55%50,805,168
2,791,639Institution3.52%50,425,375
2,505,738Institution3.16%45,261,145
2,284,907Institution2.88%41,272,275
2,203,641Institution2.78%39,804,367
1,997,153Institution2.52%36,074,575

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
3,190,415Institution4.03%57,628,466
2,505,738Institution3.16%45,261,145
2,284,907Institution2.88%41,272,275
2,203,641Institution2.78%39,804,367
1,013,388Institution1.28%18,304,827
899,710Institution1.14%16,251,462
738,384Institution0.93%13,337,430
705,216Institution0.89%12,738,317
476,627Institution0.60%8,609,314
313,029Institution0.40%5,654,243

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns Viridian Therapeutics (GB:0K1R)?
According to the latest TipRanks data, approximately 60.26% of the company's stock is held by institutional investors, 4.38% is held by insiders, and 3.03% is held by retail investors.
    What percentage of Viridian Therapeutics (GB:0K1R) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 60.26% of Viridian Therapeutics (GB:0K1R) stock is held by institutional investors.
      What percentage of Viridian Therapeutics (GB:0K1R) stock is held by retail investors?
      According to the latest TipRanks data, approximately 3.03% of Viridian Therapeutics (GB:0K1R) stock is held by retail investors.
        Who owns the most shares of Viridian Therapeutics (GB:0K1R)?
        Vanguard owns the most shares of Viridian Therapeutics (GB:0K1R).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis